BMY  valuation analysis

Basics
Name: Bristol-Myers Squibb Company
Description: Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. (more)
Industry: Drug Manufacturers-General
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 04, 2021
Market cap: $142.09B (50th)
Sales(TTM): $42.52B (61st)
Earnings(TTM): -$8.99B (1277th)

Value
FFER: 1.29 (why)
Actual price: $62.05
FFEThis is Bristol-Myers Squibb Company's the estimated price. FFEs are the denominator of the FFER ratio.: $46.57
Quantile: BMY is expensive given its fundamentals.
Prices as of EOD 2021-02-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Bristol-Myers Squibb Company's earnings decreased from $3.46B to -$8.99B in the last year.
  • Bristol-Myers Squibb Company's operating income decreased from $5.91B to -$9.19B in the last year.
Earnings / MarketCap
Bristol-Myers Squibb Company
"Drug Manufacturers-General" industry
Sales / MarketCap
Bristol-Myers Squibb Company
"Drug Manufacturers-General" industry
Book / MarketCap
Bristol-Myers Squibb Company
"Drug Manufacturers-General" industry
Equity / Assets
Bristol-Myers Squibb Company
"Drug Manufacturers-General" industry